ERBB2 and triple-negative breast carcinoma: Gallen conference in 2013, categorizing breast cancer into four subtypes: luminal A, luminal B, Human Epidermal Growth Factor Receptor 2 (HER-2) overexpression, and Triple Negative Breast Cancer (TNBC).